DSGN
Design Therapeutics Inc.
$6.44
+$0.42(+6.98%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$344.54M
Volume
90.30K
52W Range
$2.60 - $7.77
Target Price
$7.33
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $35.8M | $67.6M | $78.2M | $62.4M | ||
| Research & Development | $24.8M | $48.6M | $57.1M | $44.4M | ||
| Research Expense | $24.8M | $48.6M | $57.1M | $44.4M | ||
| Selling, General & Administrative | $11.1M | $19.0M | $21.1M | $18.0M | ||
| Selling & Marketing Expenses | $328.0K | $530.0K | -- | -- | ||
| General & Administrative Expenses | $11.1M | $19.0M | $21.1M | $18.0M | ||
| Salaries & Wages | -- | -- | $13.1M | $13.1M | ||
| Other Operating Expenses | $-402.0K | $-511.0K | $-783.0K | $-493.0K | ||
| OPERATING INCOME | ||||||
| Operating income | $-35.8M | $-67.6M | $-78.2M | $-62.4M | ||
| EBITDA | $-35.5M | $-67.2M | $-66.3M | $-49.1M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | -- | -- | $11.3M | $12.8M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | $11.3M | $12.8M | ||
| Other Income/Expense | $-298.0K | $4.3M | $11.3M | -- | ||
| Other Special Charges | $298.0K | $4.3M | $11.3M | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-35.5M | $-67.6M | $-66.9M | $-49.7M | ||
| Pre-Tax Income | $-35.5M | $-63.3M | $-66.9M | $-49.6M | ||
| INCOME TAX | ||||||
| Tax Provision | $-9.0K | $-200.0K | $-37.0K | $-102.0K | ||
| NET INCOME | ||||||
| Net Income | $-35.5M | $-63.3M | $-66.9M | $-49.6M | ||
| Net Income (Continuing Operations) | $-35.5M | $-63.3M | $-66.9M | $-49.6M | ||
| Net Income (Discontinued Operations) | $-35.5M | $-63.3M | $-66.9M | $-49.6M | ||
| Net Income (Common Stockholders) | $-35.5M | $-63.3M | $-66.9M | $-49.6M | ||
| TOTALS | ||||||
| Total Expenses | $35.8M | $67.6M | $78.2M | $62.4M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $45.9M | $55.7M | $56.0M | $56.6M | ||
| Average Shares Outstanding (Diluted) | $45.9M | $55.7M | $56.0M | $56.6M | ||
| Shares Outstanding | $55.7M | $55.9M | $56.5M | $56.8M | ||
| Basic EPS | $-0.77 | $-1.14 | $-1.19 | $-0.88 | ||
| Basic EPS (Continuing Operations) | $-0.77 | $-1.14 | $-1.19 | $-0.88 | ||
| Diluted EPS | $-0.77 | $-1.14 | $-1.19 | $-0.88 | ||
| Diluted EPS (Continuing Operations) | -- | $-1.14 | $-1.19 | $-0.88 | ||
| OTHER METRICS | ||||||
| Other Gand A | $11.1M | $19.0M | $21.1M | $18.0M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DSGN | $6.44 | +7.0% | 90.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Design Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW